Lawyers Gear Up For Round 2 Of Fosamax Bellwether

Law360, New York (June 4, 2010, 7:05 PM EDT) -- Starting over after jurors were left hopelessly deadlocked last year, lawyers for bellwether plaintiff Shirley Boles are set to launch into their second attempt to try claims against Merck & Co. Inc. over alleged devastating side effects from the use of osteoporosis drug Fosamax.

Jury selection begins Monday in the U.S. District Court for the Southern District of New York, offering plaintiffs another bite at the apple in a high-stakes case that has been designated as one of three to help lay the groundwork for litigation...
To view the full article, register now.